Dozens of benign conditions can look, feel, and even test like cancer on imaging, bloodwork, and tissue samples. In one large surgical series, about 9% of patients who underwent lung resection for suspected cancer turned out to have benign disease instead.1The Annals of Thoracic Surgery. Prevalence of Benign Disease in Patients Undergoing Resection for Suspected Lung Cancer The mimics span nearly every organ system, from inflammatory masses in the pancreas to autoimmune lesions in the brain, and the overlap is sometimes so convincing that even experienced specialists need a biopsy to tell the difference.
Lung Conditions That Look Like Cancer
The lungs are a common site for cancer look-alikes because so many things can produce a mass or a cluster of nodules on a chest scan. Infections, both common and opportunistic, are frequent culprits. Fungal infections like invasive pulmonary aspergillosis and cryptococcosis can produce growing nodules and masses that look virtually identical to tumor progression or recurrence on imaging, particularly in patients who already have a history of lung cancer.2PubMed. Opportunistic Invasive Fungal Infections Mimicking Progression of Non-Small-Cell Lung Cancer Tuberculosis and other granulomatous infections can also leave behind masses or cavities that raise red flags on a CT scan.
Sarcoidosis, an inflammatory disease that causes clusters of immune cells called granulomas to form in the lungs and lymph nodes, is another well-known mimic. Its radiographic features overlap so heavily with those of lung cancer that misdiagnosis goes in both directions: sarcoidosis gets called cancer, and cancer gets called sarcoidosis.3PubMed Central. Sarcoidosis misdiagnosed as malignant tumors: a case report In patients who already have a cancer history, sarcoidosis nodules appearing in the lungs can be mistaken for metastatic spread.4Frontiers in Oncology. Sarcoidosis misdiagnosed as pulmonary malignancy: a case report The reverse is equally dangerous: one documented case showed a delayed lung cancer diagnosis because the new mass was attributed to worsening sarcoidosis in a patient already living with the disease.5BMC Pulmonary Medicine. Delayed diagnosis of lung cancer due to misdiagnosis as worsening of sarcoidosis: a case report
Pancreatic and Digestive Tract Mimics
Pancreatic cancer is one of the most lethal cancers, so when imaging shows a mass in the head of the pancreas with symptoms like jaundice and weight loss, the clinical alarm bells ring loudly. The trouble is that autoimmune pancreatitis can produce an almost identical picture. The swelling shows up in the same location, the same blood marker (CA 19-9) that often rises in pancreatic cancer can also be elevated, and the patient can present with the same obstructive jaundice.6PubMed Central. Autoimmune pancreatitis misdiagnosed as a tumor of the head of the pancreas Because the treatment paths are so different, telling them apart matters enormously: autoimmune pancreatitis responds to steroids, while pancreatic cancer requires surgery and chemotherapy.7Clinical Gastroenterology and Hepatology. Distinguishing Pancreatic Cancer From Autoimmune Pancreatitis: A Comparison of Two Strategies
The misidentification rate is not trivial. In a series of 220 patients who underwent major surgery (removal of the head of the pancreas) for suspected pancreatic cancer, 14 of them, roughly 6%, turned out to have benign inflammatory lesions rather than cancer.8Gastrointestinal Endoscopy. Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer That is a major operation with real risks, performed on people who did not have the disease it was intended to treat. Specialized imaging protocols can help radiologists tell the two apart, but even advanced CT techniques require expert readers to spot the subtle differences.9PubMed. Dual-phase CT of autoimmune pancreatitis: a multireader study
Breast Conditions That Raise False Alarms
Fat necrosis in the breast is one of the more anxiety-inducing mimics because it can produce a firm lump, skin changes, and a suspicious-looking mass on mammography or ultrasound. Fat necrosis happens when fatty tissue in the breast breaks down, often after surgery or trauma, but sometimes without any clear trigger. On imaging, it can look strikingly like a malignant mass.10American Journal of Case Reports. Atraumatic Breast Fat Necrosis Mimicking Malignancy in End-Stage Renal Disease: A Case Report Other benign breast conditions that routinely send people for biopsies include complex sclerosing lesions (sometimes called radial scars) and intraductal papillomas, both of which can produce patterns under the microscope that look worryingly similar to cancer. Specialized staining techniques are sometimes the only way to confirm the tissue is benign.11PubMed. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions
Endometriosis and Ovarian Cancer
Endometriosis can sometimes look like advanced ovarian cancer. The overlap goes beyond imaging. CA-125, the blood marker most associated with ovarian cancer screening, is frequently elevated in women with endometriosis as well.12PubMed Central. The use of HE4, CA125 and CA72-4 biomarkers for differential diagnosis between ovarian endometrioma and epithelial ovarian cancer In some cases, the CA-125 levels can be extremely high, well into ranges that would normally point strongly toward malignancy.13PubMed Central. Elevated CA 125 in a CASE of Leaking Endometrioma When combined with other findings like fluid in the abdomen and around the lungs, the picture can closely resemble advanced ovarian cancer, enough that some patients have been prepared for extensive cancer surgery only to learn they had severe endometriosis instead.14Fertility and Sterility. Endometriosis mimicking advanced ovarian cancer
This is worth knowing because false-positive ovarian cancer screenings carry real consequences. A systematic review of ovarian screening studies found that unnecessary surgeries prompted by false positives led to significant complication rates, including infections, blood loss, bowel injury, and cardiovascular or pulmonary problems.15PubMed Central. Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic review
Prostate Mimics
Prostate cancer screening relies heavily on a blood test for prostate-specific antigen (PSA) and, increasingly, on MRI. Both can be fooled. Granulomatous prostatitis, a relatively uncommon inflammatory condition, can raise PSA levels and produce nodules on MRI that look highly suspicious for aggressive prostate cancer.16PubMed Central. Granulomatous prostatitis mimicking prostate cancer in a patient with psoriatic arthritis: a case report On MRI specifically, the appearance can be essentially indistinguishable from invasive cancer, and a biopsy is often the only way to settle the question.17PubMed Central. Granulomatous Prostatitis Mimicking Invasive Prostate Cancer A useful clinical clue is the patient’s history: granulomatous prostatitis is more common in people who have had BCG therapy (used for bladder cancer treatment) or who have certain autoimmune conditions.
Under the microscope, the challenges continue. A benign growth pattern called atypical adenomatous hyperplasia can closely mimic the small-gland pattern of prostate cancer, making it a well-known diagnostic trap for pathologists.18Modern Pathology. Benign mimickers of prostatic adenocarcinoma
Brain Lesions That Resemble Tumors
Tumefactive demyelination is a rare neurological condition in which the immune system attacks the protective coating around nerve fibers in the brain, producing large lesions that look like brain tumors on MRI.19PubMed Central. A rare case of tumefactive demyelination of brain: A case report and literature review It is sometimes considered a variant of multiple sclerosis, and its pseudotumoral appearance can also be confused with infections and strokes in addition to cancer.20PubMed Central. A challenging diagnosis of late-onset tumefactive multiple sclerosis associated to cervicodorsal syringomyelia Because brain tumors require a very different treatment approach than autoimmune conditions, getting this distinction right early has a major impact on outcomes. The lesions can cause neurological symptoms like weakness, speech problems, or seizures that closely mirror what a brain tumor would produce, adding to the confusion.
Swollen Lymph Nodes and the Lymphoma Scare
Enlarged lymph nodes are one of the most common reasons people worry about cancer, and for good reason: lymphoma is one of the more common cancers, and its hallmark is painless swollen lymph nodes. But the list of benign conditions that can enlarge lymph nodes is long, and a few are particularly convincing cancer mimics.
Kikuchi-Fujimoto disease is a self-limiting condition that causes swollen lymph nodes along with fever, fatigue, weight loss, and sometimes an enlarged liver or spleen. That symptom profile overlaps heavily with lymphoma, and Kikuchi-Fujimoto disease is frequently misdiagnosed as non-Hodgkin lymphoma before biopsy results come back.21PubMed Central. Recurrent Kikuchi-Fujimoto Disease Masquerading as Lymphoma Successfully Treated by Anakinra Other conditions in the differential include cat-scratch disease, lupus-related lymph node swelling, and infectious mononucleosis.22PubMed Central. Kikuchi-Fujimoto disease: A comprehensive review The practical takeaway is that enlarged lymph nodes, while they deserve medical evaluation, have a long list of non-cancerous explanations.
Skin Lesions and Melanoma Look-Alikes
Seborrheic keratoses, those waxy, stuck-on-looking growths that become more common with age, are completely harmless. But in a large analysis of over 9,200 lesions that dermatologists diagnosed clinically as seborrheic keratoses (or at least included in the differential), about 0.7% turned out to be melanoma on biopsy.23JAMA Dermatology. Prevalence of Melanoma Clinically Resembling Seborrheic Keratosis: Analysis of 9204 Cases That is a small percentage, but given how common seborrheic keratoses are, it means melanoma hiding behind the appearance of a harmless growth is not as rare as you might expect. This is one of the reasons dermatologists often biopsy skin lesions that look even slightly atypical rather than relying on visual assessment alone.
Bone and Soft-Tissue Mimics
Myositis ossificans is a condition in which bone forms abnormally in soft tissue, usually after an injury. At its onset, it can be clinically, radiologically, and histologically indistinguishable from soft-tissue sarcomas, a group of rare but serious cancers.24PubMed Central. Myositis ossificans mimicking sarcoma: a not so rare bioptic diagnostic pitfall The diagnostic confusion is worse when there is no clear history of trauma, because the doctor has no obvious benign explanation to consider first. Myositis ossificans can also be mistaken for bone infection or for osteosarcoma, a primary bone cancer.25PubMed Central. Non-traumatic myositis ossificans circumscripta: A diagnosis trap Timing helps, though: myositis ossificans develops a characteristic pattern of calcification on imaging over weeks to months that eventually distinguishes it from cancer, so repeat imaging at intervals is a key part of the workup.
When Blood Tests and Scans Mislead
Cancer biomarkers in the blood are useful but far from perfect. Alpha-fetoprotein (AFP), the marker most associated with liver cancer, can also be elevated in people with acute or chronic liver disease, cirrhosis, and certain hereditary conditions that have nothing to do with cancer.26PubMed Central. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma High AFP levels have also been described in acute liver failure and flares of chronic hepatitis.27Gastroenterology. Hepatocellular Carcinoma: Patients With Increasing Alpha-Fetoprotein But No Mass on Ultrasound Similarly, CA-125, as discussed with endometriosis, rises in a range of benign conditions. No single blood marker is specific enough to diagnose cancer on its own.
PET scans, which detect areas of high metabolic activity, are a powerful tool for staging and monitoring cancer, but they have a well-known blind spot: inflammation and infection light up the same way tumors do. Any site of active infection or inflammatory activity can show the same intense uptake of the radioactive tracer used in PET scans, and clinicians have to exercise caution to avoid misinterpreting these hot spots as malignancy.28Biomedicine & Pharmacotherapy. The impact of infection and inflammation in oncologic 18F-FDG PET/CT imaging Post-surgical inflammation, recent infections, and autoimmune flares are all common causes of PET scan false positives in cancer patients.
When Previous Surgery Creates the Mimic
People who have already been treated for cancer face an additional category of confusion: things left behind by the treatment itself. Foreign body granulomas, which form when the body reacts to surgical materials, can appear on follow-up scans as masses that look exactly like tumor recurrence.29PubMed Central. Intracranial Foreign Body Granuloma Mimicking Brain Tumor Recurrence: A Case Series Hemostatic agents, materials used during surgery to control bleeding, are a common trigger. In one documented case, a retained piece of an absorbable hemostatic material produced an abdominal mass four months after tumor removal that was initially read as recurrent cancer.30PubMed Central. Surgicel® (oxidized regenerated cellulose) granuloma mimicking local recurrent gastrointestinal stromal tumor: A case report
This is especially stressful for cancer survivors, who are already on high alert for any sign of recurrence. When a follow-up scan shows something new in the same area as the original tumor, both the patient and the clinical team naturally lean toward assuming the worst. Tissue biopsy is often the only way to confirm whether a post-surgical mass is a harmless granuloma or the real thing.
The Psychological Weight of a False Alarm
The harm of being told you might have cancer does not disappear when you are told you do not. A study following women who received false-positive results on screening mammography found that three years after being declared cancer-free, they still reported greater negative psychological effects compared with women who had normal results across all measured outcomes.31PubMed Central. Long-term psychosocial consequences of false-positive screening mammography Six months after the final diagnosis, the psychological impact on women with false-positive findings was comparable to that reported by women who had actually been diagnosed with breast cancer.
Beyond emotional harm, false positives lead to real physical procedures. Women flagged by ovarian cancer screening who turn out not to have cancer still undergo surgery at significant rates, and those surgeries carry complications including infections, blood loss, bowel injury, and cardiovascular problems.15PubMed Central. Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic review This is the central tension of cancer screening: catching cancer early saves lives, but every screening program that is sensitive enough to catch early cancers will inevitably flag some people who do not have cancer and send them through a frightening, sometimes painful process for nothing.
How Pathology Sorts Through the Confusion
When imaging and blood tests cannot settle the question, tissue diagnosis under a microscope is the standard next step. But even under the microscope, the boundary between benign and malignant is not always obvious. Inflammation from infections, prior treatments, or instrumentation can produce cellular changes in tissue that closely resemble precancerous or cancerous cells, a problem well documented in bladder biopsies where inflammation, therapy effects, and mechanical irritation can all produce atypical-looking cells.32PubMed Central. Diagnostically challenging cases: what are atypia and dysplasia?
Immunohistochemistry, a technique that uses antibodies to tag specific proteins in tissue, has become a critical tool for resolving ambiguous cases. In thyroid nodules, for example, panels of markers can distinguish benign from malignant lesions with a sensitivity in the range of 83% to 87%.33PubMed Central. Utility of immunohistochemical markers in differentiating benign from malignant follicular-derived thyroid nodules In breast pathology, similar staining techniques help resolve cases where benign papillomas look like cancer under the microscope and where cancers adopt patterns that mimic benign tissue.11PubMed. Usefulness of immunohistochemistry for differential diagnosis between benign and malignant breast lesions
Artificial intelligence is beginning to enter this space. An AI system trained to identify basal cell carcinoma, the most common skin cancer, on whole-slide pathology images was tested against a broad set of benign and malignant look-alikes. It achieved a sensitivity of 98% and a specificity of 97%, correctly classifying 240 out of 246 slides, with only three false positives and three false negatives.34Pathology. Artificial intelligence for basal cell carcinoma: diagnosis and distinction from histological mimics Whether AI tools will eventually reduce the rate of cancer misdiagnosis across other tissue types remains an open question, but the early results are promising as a second set of eyes for pathologists working through ambiguous slides.